The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Employee benefits advice for one of the nation's largest providers of telephone and broadband services
Advised one of the nation's largest providers of telephone and broadband services with respect to compensation and employee benefit plan issues in a more
Acquisition program of data management and destruction companies for Recall Corporation
Represented Recall Corporation and its subsidiaries in an acquisition program of data management and destruction companies in U.S. and Canadian more
Blinson v. State of North Carolina

Represented the City of Winston-Salem and Forsyth County in constitutional litigation challenging the legality of more

Trademark and unfair competition matters for Diageo North America
Represents Diageo North America in a variety of trademark and unfair competition matters, including litigation in federal district court and before more